The role of overweight and obesity in the cardiorenal syndrome

CardioRenal Medicine

Volumn 1, Issue 1, 2011, Pages 5-12

  Sowers, James R ^a,b,c,d,e   Whaley Connell, Adam ^c,d   Hayden, Melvin R ^c  

^a Divisions of Endocrinology and Metabolism   (United States)

^b University of Missouri   (United States)

^c Diabetes and Cardiovascular Center   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e D109 HSC Diabetes Center   (United States)

Author keywords

Adiposity; Cardiorenal metabolic syndrome; Chronic kidney disease; Heart failure; Metabolic dyslipidemia; Obesity

Indexed keywords

EID: 81555200338     PISSN: 16643828     EISSN: 16645502     Source Type: Journal    
DOI: 10.1159/000322822     Document Type: Review

References (70)

1. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM: Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006; 295: 1549-1555.
2. McGee DL, Diverse Populations Collaboration: Body mass index and mortality: a meta-analysis based on personlevel data from twenty-six bservational studies. Ann Epidemiol 2005; 15: 87-97.
3. Ghandehari H, Le V, Kamal-Bahl S, Bassin SL, Wong ND: Abdominal obesity and the spectrum of global cardiometabolic risks in US adults. Int J Obes (Lond) 2009; 33: 239-248.
4. Sowers JR: Obesity as a cardiovascular risk factor. Am J Med 2003; 115(suppl 8A):37S-41S.
5. Liese AD, Hense HW, Döring A, Stieber J, Keil V: Microalbuminuria, central adiposity and hypertension in the nondiabetic urban population of the MONICA Augsburg survey 1994/95. J Hum Hypertens 2001; 15: 799-804.
6. Ogden CL, Carroll MD, Flegal KM: High body mass index for age among US children and adolescents, 2003-2006. JAMA 2008; 299: 2401-2405.
7. Allcock DM, Gardner JM, Sowers JR: Relation between childhood obesity and adult cardiovascular risk. Int J Pediatr Endocrinol 2009; 2009: 108187.
8. Hampton T: Pediatric obesity guidelines released. JAMA 2008; 300: 2238.
9. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J, Sherwin RS, Caprio S: Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004; 350: 2362-2374.
10. Fabbrini E, deHaseth D, Deivanayagam S, Mohammed BS, Vitola BE, Klein S: Alterations in fatty acid kinetics in obese adolescents with increased intrahepatic triglyceride content. Obesity 2008; 17: 25-29.
11. Coppen AM, Risser JA, Vash PD: Metabolic syndrome resolution in children and adolescents after 10 weeks of weight loss. J Cardiometab Syndr 2008; 3: 205-210.
12. Fowler GC, Vasudevan DA: Type 2 diabetes mellitus: managing hemoglobin A(1c) and beyond. South Med J 2010; 103: 911-916.
13. Dagenais GR, Yi Q, Mann JF, Bosch J, Pogue J, Yusuf S: Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease. Am Heart J 2005; 149: 54-60.
14. Bakris G, Vassalotti J, Ritz E, Wanner C, Stergiou G, Molitch M, Nesto R, Kaysen GA, Sowers JR, CKD Consensus Working Group: National Kidney Foundation consensus conference on cardiovascular and kidney diseases and diabetes risk: an integrated therapeutic approach to reduce events. Kidney Int 2010; 78: 726-736.
15. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS: Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047.
16. Lackland DT, Bendall HE, Osmond C, Egan BM, Barker DJ: Low birth weights contribute to high rates of early-onset chronic renal failure in the Southeastern United States. Arch Intern Med 2000; 160: 1472-1476.
17. Cruz ML, Weigensberg MJ, Huang TT, Ball G, Shaibi GQ, Goran MI: The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity. J Clin Endocrinol Metab 2004; 89: 108-113.
18. Cossrow N, Falkner B: Race/ethnic issues in obesity and obesity-related comorbidities. J Clin Endocrinol Metab 2004; 89: 2590-2594.
19. Ward MM: Socioeconomic status and the incidence of ESRD. Am J Kidney Dis 2008; 51: 563-572.
20. White SL, Perkovic V, Cass A, Chang CL, Poulter NR, Spector T, Haysom L, Craig JC, Salmi IA, Chadban SJ, Huxley RR: Is low birth weight an antecedent of CKD in later life? A systematic review of observational studies. Am J Kidney Dis 2009; 54: 248-261.
21. CKD major public health concerns worldwide. Further ethnic disparities - African Americans, native Americans -greater rates of kidney failure as well as earlier age onset and progression than whites. International Diabetes Federation,http://www.idf.org/2009.
22. Sowers JR: Metabolic risk factors and renal disease. Kidney Int 2007; 71: 719-720.
23. Kurella M, Lo JC, Chertow GM: Metabolic syndrome and the risk of chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 2005; 16: 2134-2140.
24. Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS: Body mass index and the risk for end-stage renal disease. Ann Intern Med 2006; 144: 21-28.
25. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, Whelton PK, He J: The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 2004; 140: 167-174.
26. Jee SH, Boulware LE, Guallar E, Suh I, Appel LJ, Miller ER 3rd: Direct, progressive association of cardiovascular risk factors with incident proteinuria: results from the Korea Medical Insurance Corporation (KMIC) study. Arch Intern Med 2005; 165: 2299-2304.
27. Tanaka H, Shiohira Y, Uezu Y, Higa A, Iseki K: Metabolic syndrome and chronic kidney disease in Okinawa, Japan. Kidney Int 2006; 69: 369-374.
28. Lea J, Cheek D, Thornley-Brown D, Appel L, Agodoa L, Contreras G, Gassman J, Lash J, Miller ER 3rd, Randall O, Wang X, McClellan W, AASK Study Investigators: Metabolic syndrome, proteinuria, and the risk of progressive CKD in hypertensive African Americans. Am J Kidney Dis 2008; 51: 732-740.
29. Lucove J, Vupputuri S, Heiss G, North K, Russell M: Metabolic syndrome and the development of CKD in American Indians: the Strong Heart Study. Am J Kidney Dis 2008; 51: 21-28.
30. Whaley-Connell A, Pavey BS, McCullough PA, Saab G, Li S, McFarlane SI, Chen SC, Vassalotti JA, Collins AJ, Bakris G, Sowers JR, KEEP Investigators: Dysglycemia predicts cardiovascular and kidney disease in the Kidney Early Evaluation Program. J Clin Hypertens (Greenwich) 2010; 12: 51-58.
31. Kasiske BL, Napier J: Glomerular sclerosis in patients with massive obesity. Am J Nephrol 1985; 5: 45-50.
32. Iseki K, Ikemiya Y, Kinjo K, Inoue T, Iseki C, Takishita S: Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 2004; 65: 1870-1876.
33. Ejerblad E, Fored CM, Lindblad P, Fryzek J, McLaughlin JK, Nyrén O: Obesity and risk for chronic renal failure. J Am Soc Nephrol 2006; 17: 1695-1702.
34. Tomaszewski M, Charchar FJ, Maric C, McClure J, Crawford L, Grzeszczak W, Sattar N, Zukowska-Szczechowska E, Dominiczak AF: Glomerular hyperfiltration: a new marker of metabolic risk. Kidney Int 2007; 71: 816-821.
35. Griffin KA, Kramer H, Bidani AK: Adverse renal consequences of obesity. Am J Physiol Renal Physiol 2008; 294:F685-F696.
36. Wuerzner G, Pruijm M, Maillard M, Bovet P, Renaud C, Burnier M, Bochud M: Marked association between obesity and glomerular hyperfiltration: a cross-sectional study in an African population. Am J Kidney Dis 2010; 56: 303-312.
37. Levey AS, Kramer H: Obesity, glomerular hyperfiltration, and the surface area correction. Am J Kidney Dis 2010: 56: 255-258.
38. Morales E, Valero MA, León M, Hernández E, Praga M: Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies. Am J Kidney Dis 2003; 41: 319-327.
39. Chagnac A, Weinstein T, Herman M, Hirsh J, Gafter U, Ori Y: The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol 2003; 14: 1480-1486.
40. Tran HA: Reversible obesity-related glomerulopathy following weight reduction. Med J Aust 2006; 184: 367.
41. Navarro-Díaz M, Serra A, Romero R, Bonet J, Bayés B, Homs M, Pérez N, Bonal J: Effect of drastic weight loss after bariatric surgery on renal parameters in extremely obese patients: long-term follow-up. J Am Soc Nephrol 2006; 17:S213-S217.
42. Serra A, Granada ML, Romero R, Bayés B, Cantón A, Bonet J, Rull M, Alastrue A, Formiguera X: The effect of bariatric surgery on adipocytokines, renal parameters and other cardiovascular risk factors in severe and very severe obesity:1-year follow-up. Clin Nutr 2006; 25: 400-408.
43. Nakagawa T, Hu H, Zharikov S, Tuttle KR, Short RA, Glushakova O, Ouyang X, Feig DI, Block ER, Herrera-Acosta J, Patel JM, Johnson RJ: A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol 2006; 290:F625-F631.
44. Bell RC, Carlson JC, Storr KC, Herbert K, Sivak J: High-fructose feeding of streptozotocin-diabetic rats is associated with increased cataract formation and increased oxidative stress in the kidney. Br J Nutr 2000; 84: 575-582.
45. Sánchez-Lozada LG, Tapia E, Jiménez A, Bautista P, Cristóbal M, Nepomuceno T, Soto V, Avila-Casado C, Nakagawa T, Johnson RJ, Herrera-Acosta J, Franco M: Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats. Am J Physiol Renal Physiol 2007; 292:F423-F429.
46. Gersch MS, Mu W, Cirillo P, Reungjui S, Zhang L, Roncal C, Sautin YY, Johnson RJ, Nakagawa T: Fructose, but not dextrose, accelerates the progression of chronic kidney disease. Am J Physiol Renal Physiol 2007; 293:F1256-F1261.
47. Lee JE, Kim YG, Choi YH, Huh W, Kim DJ, Oh HY: Serum uric acid is associated with microalbuminuria in prehypertension. Hypertension 2006; 47: 962-967.
48. Saldana TM, Basso O, Darden R, Sandler DP: Carbonated beverages and chronic kidney disease. Epidemiology 2007; 18: 501-506.
49. Johnson RJ, Segal MS, Sautin Y, Nakagawa T, Feig DI, Kang DH, Gersch MS, Benner S, Sánchez-Lozada LG: Potential role of sugar (fructose) in the epidemic of hypertension, obesity, and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am J Clin Nutr 2007; 86: 899-906.
50. Bomback AS, Derebail VK, Shoham DA, Anderson CA, Steffen LM, Rosamond WD, Kshirsagar AV: Sugar-sweetened soda consumption, hyperuricemia, and kidney disease. Kidney Int 2010; 77: 609-616.
51. Shoham DA, Durazo-Arvizu R, Kramer H, Luke A, Vupputuri S, Kshirsagar A, Cooper RS: Sugary soda consumption and albuminuria: results from the National Health and Nutrition Examination Survey, 1999-2004. PLoS One 2008; 3:e3431.
52. Choi JW, Ford ES, Gao X, Choi HK: Sugar-sweetened soft drinks, diet soft drinks, and serum uric acid level: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 2008; 59: 109-116.
53. He FJ, Marrero NM, MacGregor GA: Salt intake is related to soft drink consumption in children and adolescents: a link to obesity? Hypertension 2008; 51: 629-634.
54. Palmer JR, Boggs DA, Krishnan S, Hu FB, Singer M, Rosenberg L: Sugar-sweetened beverages and incidence of type 2 diabetes mellitus in African American women. Arch Intern Med 2008; 168: 1487-1492.
55. Assy N, Nasser G, Kamayse I, Nseir W, Beniashvili Z, Djibre A, Grosovski M: Soft drink consumption linked with fatty liver in the absence of raditional risk factors. Can J Gastroenterol 2008; 22: 811-816.
56. WRITING GROUP MEMBERS, Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger VL, Rosamond W, Sacco R, Sorlie P, Roger VL, Thom T, Wasserthiel-Smoller S, Wong ND, Wylie-Rosett J, American Heart Association Statistics Committee and Stroke Statistics Subcommittee: Heart disease and stroke statistics - 2010 update: a report from the American Heart Association. Circulation 2010; 121:e46-e215.
57. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM: Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006; 355: 251-259.
58. Alpert MA, Lambert CR, Terry BE, Cohen MV, Mukerji V, Massey CV, Hashimi MW, Panayiotou H: Interrelationship of left ventricular mass, systolic function and diastolic filling in normotensive morbidly obese patients. Int J Obes Relat Metab Disord 1995; 19: 550-557.
59. Lauer MS, Anderson KM, Kannel WB, Levy D: The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study. JAMA 1991; 266: 231-236.
60. Zhou X, Ma L, Habibi J, Whaley-Connell A, Hayden MR, Tilmon RD, Brown AN, Kim JA, Demarco VG, Sowers JR: Nebivolol improves diastolic dysfunction and myocardial remodeling through reductions in oxidative stress in the Zucker obese rat. Hypertension 2010; 55: 880-888.
61. Nishimura RA, Tajik AJ: Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician's Rosetta Stone. J Am Coll Cardiol 1997; 30: 8-18.
62. Sawyer DB, Siwik DA, Xiao L, Pimentel DR, Singh K, Colucci WS: Role of oxidative stress in myocardial hypertrophy and failure. J Mol Cell Cardiol 2002; 34: 379-388.
63. Sorescu D, Griendling KK: Reactive oxygen species, mitochondria, and NAD(P)H oxidases in the development and progression of heart failure. Congest Heart Fail 2002; 8: 132-140.
64. Takimoto E, Kass DA: Role of oxidative stress in cardiac hypertrophy and remodeling. Hypertension 2007; 49: 241-248.
65. Ritchie RH, Delbridge LM: Cardiac hypertrophy, substrate utilization and metabolic remodelling: cause or effect? Clin Exp Pharmacol Physiol 2006; 33: 159-166.
66. Russo I, Del Messe P, Doronzo G, Mattiello L, Viretto M, Bosia A, Anfossi G, Trovati M: Resistance to the nitric oxide/ cyclic guanosine 5'-onophosphate/protein kinase G pathway in vascular smooth muscle cells from the obese Zucker rat, a classical animal model of insulin resistance: role of oxidative stress. Endocrinology 2008; 149: 1480-1489.
67. Massion PB, Dessy C, Desjardins F, Pelat M, Havaux X, Belge C, Moulin P, Guiot Y, Feron O, Janssens S, Balligand JL: Cardiomyocyte-restricted overexpression of endothelial nitric oxide synthase (NOS3) attenuates beta-adrenergic stimulation and reinforces vagal inhibition of cardiac contraction. Circulation 2004; 110: 2666-2672.
68. Whaley-Connell A, Govindarajan G, Habibi J, Hayden MR, Cooper SA, Wei Y, Ma L, Qazi M, Link D, Karuparthi PR, Stump CS, Ferrario CM, Sowers JR: Angiotensin-II mediated oxidative stress promotes myocardial tissue remodeling in the transgenic TG (mRen2) 27 Ren2 rat. Am J Physiol Endocrinol Metab 2007; 293:E355-E363.
69. Kobayasi R, Akamine EH, Davel AP, Rodrigues MA, Carvalho CR, Rossoni LV: Oxidative stress and inflammatory mediators contribute to endothelial dysfunction in high-fat diet-induced obesity in mice. J Hypertens 2010; 28: 2111-2119.
70. House AA, Haapio M, Lassus J, Bellomo R, Ronco C: Therapeutic strategies for heart failure in cardiorenal syndromes. Am J Kidney Dis 2010; 56: 759-773.